Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.

Literature DB >> 30623356

Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.

Kensei Tobinai¹, Toshiki Uchida², Noriko Fukuhara³, Tomoaki Nishikawa⁴.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2019 PMID： 30623356 DOI： 10.1007/s12185-018-02577-8

Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490

× No keyword cloud information.

1 in total

1. Safety and tolerability of ibrutinib monotherapy in Japanese patients with relapsed/refractory B cell malignancies.

Authors: Kensei Tobinai; Michinori Ogura; Kenichi Ishizawa; Tatsuya Suzuki; Wataru Munakata; Toshiki Uchida; Tomohiro Aoki; Takanobu Morishita; Yoko Ushijima; Satoko Takahara
Journal: Int J Hematol Date: 2015-11-20 Impact factor: 2.490

1 in total

Review 1. Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.

Authors: Dok Hyun Yoon; Junning Cao; Tsai-Yun Chen; Koji Izutsu; Seok Jin Kim; Yok Lam Kwong; Tong Yu Lin; Lim Soon Thye; Bing Xu; Deok Hwan Yang; Won Seog Kim
Journal: J Hematol Oncol Date: 2020-03-17 Impact factor: 17.388

1 in total